Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 28, 2014; 20(12): 3173-3179
Published online Mar 28, 2014. doi: 10.3748/wjg.v20.i12.3173
Published online Mar 28, 2014. doi: 10.3748/wjg.v20.i12.3173
Table 1 Acquired risk factors for venous thromboembolism in inflammatory bowel disease patients and modalities for their prevention and/or treatment
Risk factor | Prevention/treatment modality |
Active disease ("inflammatory burden") | Effective anti-inflammatory treatment |
Smoking | Programmes for smoking cessation |
Oral contraceptive use | Advise alternative methods of contraception |
Hyperhomocysteinaemia | Assess the presence of vitamin deficiency (vitamins B6 and B12 and folic acid) and correct if necessary |
Dehydration | Provide adequate hydration |
Prolonged immobilisation | Early mobilisation, especially after surgery; graduated compression stockings or pneumatic devices |
Infections | Timely diagnosis and treatment of infections |
Indwelling catheters | Limit the use of venous catheters; when possible, administer oral and enteral nutrition |
Obesity | Encourage weight loss (diet, exercise) |
Long-distance travel | Frequent ambulation, exercise, hydration |
Table 2 Published guidelines for the prevention of venous thromboembolism in inflammatory bowel disease patients
Scientific society (reference) | Recommendations | Type of population at risk |
European Crohn's and Colitis Organisation (ECCO)[29] | Mechanical thromboprophylaxis and/or heparin administration (UH or LMWH) | UC |
European Crohn's and Colitis Organisation (ECCO)[28] | Consider VTE prophylaxis (UH, LMWH, or fondaparinux) in all hospitalised patients | CD |
British Society of Gastroenterology (BSG)[31] | Pharmacological VTE prophylaxis for hospitalised patients with severe UC | UC |
American College of Gastroenterology (ACG)[30] | VTE prophylaxis with heparin for hospitalised patients with severe UC | UC |
American College of Chest Physicians (ACCP)[27] | Mechanical thromboprophylaxis with GCS or IPC; anticoagulant thromboprophylaxis with LMWH, UH or fondaparinux when bleeding risk decreases | Acutely ill hospitalised medical patients at increased risk of thrombosis who are bleeding or at high risk of bleeding |
- Citation: Papa A, Gerardi V, Marzo M, Felice C, Rapaccini GL, Gasbarrini A. Venous thromboembolism in patients with inflammatory bowel disease: Focus on prevention and treatment. World J Gastroenterol 2014; 20(12): 3173-3179
- URL: https://www.wjgnet.com/1007-9327/full/v20/i12/3173.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i12.3173